Innovative Coral-Inspired Capsule Enables Noninvasive Sampling of Small Intestine Bacteria
A novel coral-inspired ingestible capsule offers a noninvasive way to sample bacteria from the small intestine, providing new insights into the gut microbiome and its role in health and disease.
Researchers have developed a groundbreaking ingestible device inspired by marine coral structures to sample bacteria from the small intestine, an area typically inaccessible using traditional methods. This novel capsule, called CORAL (Cellularly Organized Repeating Lattice), draws upon the intricate, porous patterns found in natural coral formations, which host diverse microbial communities. The device is designed to passively traverse the digestive tract, trapping bacteria along its maze-like channels created through advanced 3D printing techniques using Triply Periodic Minimal Surfaces (TPMS). Unlike conventional sampling tools that rely on electronics or magnetic components, CORAL operates without batteries or moving parts, ensuring a simple, scalable, and safe application.
The capsule begins sampling once it reaches the small intestine, protected by a coating that withstands stomach acid. In animal studies, CORAL successfully captured distinct bacterial populations characteristic of the upper gut, including beneficial bacteria like Lactobacillus, different from those found in fecal samples. This approach provides a more accurate representation of the small intestine’s microbiome, which plays a vital role in immune function, metabolism, and disease development.
Understanding the microbial communities in the small intestine could revolutionize diagnostics and treatments for various conditions such as immune disorders, metabolic diseases, and mental health issues, which studies increasingly link to gut health. The researchers believe that this technology offers a new, noninvasive window into the microbiome, addressing the limitations of stool-based analyses that mainly reflect bacteria from the large intestine.
Future steps include scaling the capsule for human use, developing retrieval methods, and conducting safety testing before clinical trials. The team envisions this innovation as part of a broader movement toward personalized, microbiome-targeted therapies, leveraging the natural structures found in marine life to solve complex biological challenges.
Source: https://medicalxpress.com/news/2025-09-coral-capsule-samples-hidden-bacteria.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Enhancing AI Accuracy in Antibody Identification Through Challenging Negative Data
Innovative research shows that training AI models with challenging negative data significantly improves their ability to identify effective antibodies, boosting drug discovery and biomedical research.
Innovative Topical Fluorescent Imaging Safely Detects Basal Cell Carcinoma Quickly
A new topical fluorescent agent, PARPi-FL, enables rapid, safe, and non-invasive detection of basal cell carcinoma through intact skin, promising improved diagnosis and management of skin cancer.
FDA Approves Wegovy for Treatment of Serious Liver Disease
The FDA has approved Wegovy, a GLP-1 receptor agonist, to treat serious fatty liver disease (MASH), offering new hope to millions affected by this condition. Learn more about how this groundbreaking approval could impact liver health management.
The Overlooked Role of Weight-Loss Behaviors in Diagnosing Eating Disorders
A recent study reveals significant gaps in current eating disorder assessments, highlighting the need to include a broader range of weight-loss behaviors for accurate diagnosis and personalized treatment.